|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400089729 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-13 16:28:42 |
|
注册时间: Date of Registration: |
2024-09-13 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
帕金森病动词产生与理解障碍的机制及干预效果的研究 |
|
Public title: |
A study on the mechanism and intervention effects of verb production and comprehension disorders in Parkinson's disease |
|
注册题目简写: |
帕金森病动词障碍 |
|
English Acronym: |
Parkinson's disease verb disorder |
|
研究课题的正式科学名称: |
帕金森病动词产生与理解障碍的机制及干预效果的研究 |
|
Scientific title: |
A study on the mechanism and intervention effects of verb production and comprehension disorders in Parkinson's disease |
|
研究课题代号(代码): Study subject ID: |
LL-2024-008 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘欢欢 |
研究负责人: |
刘欢欢;李晓红 |
|
Applicant: |
Hunahuan Liu |
Study leader: |
Hunahuan Liu; Xiaohong Li |
|
申请注册联系人电话: Applicant telephone: |
+86 188 4261 5536 |
研究负责人电话:
Study leader's |
+86 188 4261 5536 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
abcde69503@126.com |
研究负责人电子邮件: Study leader's E-mail: |
abcde69503@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
辽宁省大连市沙河口区黄河路850号 |
研究负责人通讯地址: |
辽宁省大连市沙河口区黄河路850号 辽宁省大连市中山区三八广场8号 |
|
Applicant address: |
No.850 Huanghe Road, Shahekou District, Dalian City, Liaoning Province |
Study leader's address: |
No.850 Huanghe Road, Shahekou District, Dalian City, Liaoning Province No. 8, Sanba Square, Zhongshan District, Dalian, Liaoning |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
辽宁师范大学 |
||
|
Applicant's institution: |
Liaoning Normal University |
||
|
研究负责人所在单位: |
辽宁师范大学/大连市友谊医院 |
||
|
Affiliation of the Leader: |
Liaoning Normal University/ Dalian Friendship Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
LL-2024-008 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
大连市友谊医院伦理委员会 |
||
|
Name of the ethic committee: |
Dalian Friendship Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-15 00:00:00 | ||
|
伦理委员会联系人: |
秦怡 |
||
|
Contact Name of the ethic committee: |
Yi Qin |
||
|
伦理委员会联系地址: |
大连市友谊医院伦理委员会 |
||
|
Contact Address of the ethic committee: |
Dalian Friendship Hospital Ethics Committee |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 411 8271 8822 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
大连市友谊医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Dalian Friendship Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
辽宁省大连市中山区三八广场8号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 8, Sanba Square, Zhongshan District, Dalian, Liaoning |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China |
||||||||||||||||||||||
|
研究疾病: |
帕金森 |
||||||||||||||||||||||
|
Target disease: |
Parkinson |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
基于具身认知理论的动感共振原理,我们把帕金森疾病的运动功能与语言联系起来,试图探究帕金森病患者的动词产出与理解障碍的认知神经机制,明确运动功能与语言之间的关系,这对于了解帕金森疾病的机理具有重要意义,即运动功能的失调导致了语言感知出现了障碍。同时从动词训练和提高执行功能的角度,改善帕金森病语言障碍的效果。这说明帕金森疾病需要考虑从多个角度执行治疗,不仅仅是运动角度,还有语言的训练和执行功能的训练。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the theory of embodied cognition and the principle of dynamic resonance, we connect the motor function of Parkinson's disease with language, attempting to explore the cognitive neural mechanisms of verb production and comprehension disorders in Parkinson's disease patients, and clarify the relationship between motor function and language. This is of great significance for understanding the mechanism of Parkinson's disease, that is, the dysfunction of motor function leads to language perception disorders. At the same time, from the perspective of verb training and improving executive function, the effect of improving language disorders in Parkinson's disease can be achieved. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
帕金森组:1)年龄>18岁,符合2015年国际运动障碍协会帕金森病的诊断标准; 2)H-Y1-3期;统一帕金森评定量表(MDS-Unified Parkinson's Disease Rating Scale,MDS-UPDRS)第三部分中“3.1言语”评分为1-3分,基线认知测评结果为非痴呆。3)入组后及研究期间口服抗PD药物种类和剂量保持不变。 健康组:1)年龄>18岁;2)无帕金森疾病以及其他疾病;3)如组后无口服药物等现象。 |
||||||||||||||||||||||
|
Inclusion criteria |
PD group: 1) Age>18 years old, meets the diagnostic criteria for Parkinson's disease by the 2015 International Association for Movement Disorders; 2) H-Y1-3 phase; The MDS Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part 3, has a 3.1 speech score of 1-3 and a baseline cognitive assessment result of non dementia. 3) The types and doses of oral anti PD drugs remained unchanged after enrollment and during the study period. HC group: 1) Age>18 years old; 2) No Parkinson's disease or other illnesses; 3) If there is no phenomenon of oral medication after the group. |
||||||||||||||||||||||
|
排除标准: |
1.继发性帕金森综合征和帕金森叠加综合征; 2.并存除PD以外的神经系统疾病; 3.无法配合临床量表测评、言语训练、执行功能训练、近红外成像检查等; 4.左利手。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Secondary Parkinson's syndrome and Parkinson's superimposed syndrome; 2. Coexistence of neurological disorders other than PD; 3. Unable to cooperate with clinical scale evaluation, speech training, executive function training, near-infrared imaging examination, etc. 4.Left handedness. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-04-15 00:00:00至 To 2025-04-15 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-04-18 00:00:00 至 To 2025-04-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
李晓红采用基于单位均匀分布的随机数生成方法,即帕金森病人随机生成一个序列,按1:1:1随机分配入速度动词训练组(组1)、部位动词训练组(组2)、威斯康星测试训练组(组3),每组30例。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Xiaohong Li used a random number generation method based on unit uniform distribution, in which Parkinson's patients randomly generated a sequence and were randomly assigned to a speed verb training group (Group 1), a part verb training group (Group 2), and a Wisconsin test training group (Group 3) at a ratio of 1:1:1, with 30 cases in each group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
共享日期: 2025年6月3日,方式为:OSF https://accounts.osf.io/login?service=https://osf.io/myprojects/#preprints |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
sharing date: June 3, 2025, method: OSF https://accounts.osf.io/login?service=https://osf.io/myprojects/#preprints |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表,fNIRS采集设备 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case record form, fNIRS collection equipment |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |